A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients
Year: 2015
Type: article
Study design: Clinical Trial
Source: Transplantation
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Cedars-Sinai Medical Center
OpenAlex ID: W412766306
